Opus Genetics, Inc
Nasdaq IRD · Durham, NC
Works in Genetic & rare · Ophthalmology
Opus Genetics, Inc is a clinical trial sponsor based in Durham, NC, listed as Nasdaq IRD. It has 3 active clinical trials with 42 planned participants, in Genetic & rare and Ophthalmology. Since 2021 it has completed 1 trial and stopped 0 early.
Trial track record · since 2021
Financials · Nasdaq IRD
Fundraising
Pipeline · 3 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Opus Genetics, Inc
Opus Genetics, Inc is lead sponsor of 3 active clinical trials on ClinicalTrials.gov, with 42 planned participants, in Genetic & rare, Ophthalmology. Since 2021 it has completed 1 trial and stopped 0 early.
Opus Genetics, Inc is based in Durham, NC and is listed as Nasdaq IRD. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Opus Genetics, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-08.
Approve Suite is not affiliated with Opus Genetics, Inc.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.